Clinical Trial Update: PK in Pts With HRPC & Skeletal Metastes [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in patients with hormone-refractory prostate cancer and skeletal metastases; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Bayer | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED